Recruitment across two decades of NIH-funded Alzheimer’s disease clinical trials
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1758-9193
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Recruitment across two decades of NIH-funded Alzheimer’s disease clinical trials ; volume:15 ; number:1 ; day:2 ; month:2 ; year:2023 ; pages:1-9 ; date:12.2023
Alzheimer's research & therapy ; 15, Heft 1 (2.2.2023), 1-9, 12.2023
- Urheber
-
Ritchie, Marina
Gillen, Daniel L.
Grill, Joshua D.
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1186/s13195-023-01177-x
- URN
-
urn:nbn:de:101:1-2023040721131234063443
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:51 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Ritchie, Marina
- Gillen, Daniel L.
- Grill, Joshua D.
- SpringerLink (Online service)
Ähnliche Objekte (12)
Mapping of Alzheimer’s disease related data elements and the NIH Common Data Elements
Alzheimer’s disease neuropathological change three decades after iatrogenic amyloid-β transmission
Cholesterol alters mitophagy by impairing optineurin recruitment and lysosomal clearance in Alzheimer’s disease
The Alzheimer’s Prevention Registry: A Large Internet-Based Participant Recruitment Registry to Accelerate Referrals to Alzheimer’s-Focused Studies
Alzheimer’s Disease
Bridging the Gap: Culturally Responsive Strategies for NIH Trial Recruitment
Recruitment into the Alzheimer Prevention Trials (APT) Webstudy for a Trial-Ready Cohort for Preclinical and Prodromal Alzheimer’s Disease (TRC-PAD)
Recruitment and retention of participant and study partner dyads in two multinational Alzheimer’s disease registration trials
Return on investment in science: twenty years of European Commission funded research in Alzheimer’s dementia, breast cancer and prostate cancer
Patient consent to publication and data sharing in industry and NIH-funded clinical trials
Alzheimer
Alzheimer
Mapping of Alzheimer’s disease related data elements and the NIH Common Data Elements
Alzheimer’s disease neuropathological change three decades after iatrogenic amyloid-β transmission
Cholesterol alters mitophagy by impairing optineurin recruitment and lysosomal clearance in Alzheimer’s disease
The Alzheimer’s Prevention Registry: A Large Internet-Based Participant Recruitment Registry to Accelerate Referrals to Alzheimer’s-Focused Studies
Alzheimer’s Disease
Bridging the Gap: Culturally Responsive Strategies for NIH Trial Recruitment
Recruitment into the Alzheimer Prevention Trials (APT) Webstudy for a Trial-Ready Cohort for Preclinical and Prodromal Alzheimer’s Disease (TRC-PAD)
Recruitment and retention of participant and study partner dyads in two multinational Alzheimer’s disease registration trials
Return on investment in science: twenty years of European Commission funded research in Alzheimer’s dementia, breast cancer and prostate cancer
Patient consent to publication and data sharing in industry and NIH-funded clinical trials
Alzheimer
Alzheimer
Mapping of Alzheimer’s disease related data elements and the NIH Common Data Elements
Alzheimer’s disease neuropathological change three decades after iatrogenic amyloid-β transmission
Cholesterol alters mitophagy by impairing optineurin recruitment and lysosomal clearance in Alzheimer’s disease
The Alzheimer’s Prevention Registry: A Large Internet-Based Participant Recruitment Registry to Accelerate Referrals to Alzheimer’s-Focused Studies
Alzheimer’s Disease
Bridging the Gap: Culturally Responsive Strategies for NIH Trial Recruitment
Recruitment into the Alzheimer Prevention Trials (APT) Webstudy for a Trial-Ready Cohort for Preclinical and Prodromal Alzheimer’s Disease (TRC-PAD)
Recruitment and retention of participant and study partner dyads in two multinational Alzheimer’s disease registration trials
Return on investment in science: twenty years of European Commission funded research in Alzheimer’s dementia, breast cancer and prostate cancer
Patient consent to publication and data sharing in industry and NIH-funded clinical trials
Alzheimer